2017-03-13,Bellerophon Reports Fourth Quarter 2016 Financial Results And Provides Business Update
2017-01-04,Bellerophon Therapeutics Announces FDA Acceptance Of Modifications To INOpulse Pulmonary Arterial Hypertension Phase 3 Program
2016-12-22,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-11-23,Bellerophon Therapeutics, Inc. Announces $12 Million Public Offering
2016-11-08,Bellerophon Reports Third Quarter 2016 Financial Results And Provides Business Update
2016-11-01,INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Bellerophon Therapeutics, Inc. And Advises Investors With Losses To Contact The Firm
2016-11-01,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Bellerophon Therapeutics, Inc. (BLPH)
2016-10-26,Johnson & Weaver, LLP Initiates Investigations Of Bellerophon Therapeutics, Inc., KemPharm, Inc., Neos Therapeutics, Inc., CommVault Systems, Inc. And Resource Capital Corp.
2016-09-20,Bellerophon Therapeutics Announces Planned Management Transition By Year-End 2016
2016-09-06,Bellerophon To Present At The 18th Annual Rodman & Renshaw Global Investment Conference
2016-08-09,Bellerophon Reports Second Quarter 2016 Financial Results And Provides Business Update
2016-07-25,Bellerophon Receives Approval To Commence Phase 2 Trial In PH-COPD
2016-06-16,Bellerophon Therapeutics Announces Enrollment Of The First Patient In The INOvation-1 Phase 3 Clinical Trial For Pulmonary Arterial Hypertension (PAH)
2016-05-13,6 Stocks Under $10 Making Big Moves Higher
2016-05-10,Bellerophon Reports First Quarter 2016 Financial Results And Provides Business Update
2016-03-21,Bellerophon Reports 2015 Financial Results And Provides Business Update
2016-03-14,Bellerophon Therapeutics To Hold Full Year 2015 Financial Results Conference Call On Monday March 21, 2016
2016-03-04,Bellerophon Therapeutics To Present At The Cowen And Company 36th Annual Health Care Conference
2016-03-02,Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2016-02-23,Bellerophon Therapeutics Appoints Fabian Tenenbaum As Chief Financial Officer And Chief Business Officer
2016-02-16,Bellerophon Therapeutics Appoints Mary Ann Cloyd As An Independent Board Member
2016-02-09,Bellerophon Therapeutics Announces Positive Data From The Final Analysis Of The Phase 2 Long-Term Extension Study Of INOpulse For Treatment Of Pulmonary Arterial Hypertension
2016-02-03,Bellerophon To Participate In LEERINK Partners 5th Annual Global Healthcare Conference
2016-01-21,Bellerophon Therapeutics Announces Notice Of Intention To Grant A European Patent Supporting Its INOpulse Program
2016-01-19,Bellerophon Therapeutics Receives EC Certification For New INOpulseÂ® Drug-Device Delivery System
2015-11-12,Bellerophon Reports 2015 Third Quarter Operational And Financial Results
2015-10-01,5 Stocks Under $10 Set to Soar
2015-09-30,Bellerophon Announces Functional Respiratory Imaging Data From Company Sponsored Clinical Trial Of INOpulse(R) In COPD Patients With Pulmonary Hypertension Presented Today At The European Respiratory Society (ERS) International Congress
2015-09-24,Bellerophon Therapeutics Announces Positive Data From Interim Analysis Of Phase 2 Long-Term Extension Study Of INOpulse(R) For Treatment Of Pulmonary Arterial Hypertension
2015-09-15,Bellerophon Therapeutics Announces Leadership Team Changes
2015-09-03,Bellerophon To Present In Upcoming Investor Conferences
2015-08-17,5 Stocks Ready for Breakouts
2015-08-13,Bellerophon Reports 2015 Second Quarter Operational And Financial Results
2015-07-29,Bellerophon Therapeutics Expands License Agreement With INO Therapeutics To Develop INOpulse(R) For Three Additional Cardiopulmonary Diseases
2015-07-27,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Of Bellerophon Therapeutics LLC And Its Board Of Directors In Connection With Possible Violations Of Federal Securities Laws
2015-07-27,Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial For Bioabsorbable Cardiac Matrix (BCM)
2015-07-01,Bellerophon Therapeutics Announces Management And Board Additions
2015-05-27,Bellerophon Therapeutics Presents Late-Breaking Poster At The European Society Of Cardiology's Heart Failure 2015/2nd World Congress On Acute Heart Failure
2015-05-20,Bellerophon Therapeutics Adds To Experienced Drug And Device Development Management Team
2015-05-15,Bellerophon Reports 2015 First Quarter Financial And Operational Results
2015-05-13,Bellerophon Therapeutics Appoints Two New Independent Board Members
2015-05-07,Bellerophon Therapeutics Forms Scientific Advisory Board For INOpulse(R) Programs
2015-05-05,Bellerophon Therapeutics To Present Late-Breaking Poster At The European Society Of Cardiology's Heart Failure 2015/2nd World Congress On Acute Heart Failure
2015-03-31,Bellerophon Reports 2014 Full Year Financial And Operational Results
2015-03-25,Bellerophon Therapeutics Selects Flextronics To Manufacture The Mark2, Next-Generation INOpulse(R) Device
2015-03-16,Bellerophon Therapeutics To Ring The NASDAQ Stock Market Closing Bell
2015-02-13,Bellerophon Therapeutics Announces Pricing Of Its Initial Public Offering
,
,
,
,
